Assessing local invasion in cervical cancer: the diagnostic performance of transrectal contrast-enhanced ultrasonography
British Journal of Radiology · 2026
DOI: 10.1093/bjr/tqaf283 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2026. Verfasst von Juan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Contrast Media. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Interdisciplinary Program of Shanghai Jiao Tong University, Shanghai Natural Science Foundation, Key Specialty of Changning District, Shanghai, China.
Abstract (Originalsprache)
Objectives
To evaluate the diagnostic performance of transrectal ultrasound (TR-US) combined with contrast-enhanced TR-US (TR-CEUS) against MRI and histopathology for assessing cervical cancer local invasion, and to validate the “rim sign” as a biomarker for parametrial exclusion.
Methods
A retrospective study of 69 cervical cancer patients (54 surgical, 15 neoadjuvant therapy recipients) undergoing TR-US, TR-CEUS, and MRI was conducted. Tumour dimensions, vaginal/parametrial invasion, and the “rim sign” were evaluated. Diagnostic agreement was assessed using intraclass correlation coefficients (ICC) and Cohen’ s κ, while the specificity and negative predictive value (NPV) of the “rim sign” were calculated.
Results
TR-CEUS improved TR-US reliability in tumour measurement (ICC = 0.751 to 0.784), achieving MRI-comparable accuracy (ICC = 0.804 vs. histopathology). Combined TR-US/TR-CEUS enhanced interobserver consistency for vaginal infiltration (κ = 0.621 to 0.694) and parametrial invasion (κ = 0.579 to 0.678) compared to TR-US alone. TR-US/TR-CEUS showed good agreement with histopathology (κ = 0.672) and MRI (κ = 0.789) for parametrial assessment than TR-US (κ = 0.563/0.679). The “rim sign” demonstrated 95.8% specificity and 92.0% NPV for parametrial exclusion.
Conclusions
TR-US/TR-CEUS achieves diagnostic accuracy comparable to MRI while improving observer consistency. The “rim sign” serves as a high-specificity biomarker for preoperative parametrial exclusion, offering a cost-effective alternative to MRI. Advances in knowledge This study provides quantitative evidence of TR-CEUS improving diagnostic reproducibility for cervical cancer invasion. The “rim sign” is identified as a novel imaging biomarker with high specificity for parametrial preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
- Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
- Department of Ultrasound, Shanghai Changning Maternity and Infant Health Hospital, East China Normal University, Shanghai 200050, China.
- Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
ORCID-Profile: Fan Li
Förderung
- Interdisciplinary Program of Shanghai Jiao Tong University
- Shanghai Natural Science Foundation
- Key Specialty of Changning District, Shanghai, China
Zitieren
APA
Zhang, J., Jin, L. F., Jia, C., Zhang, H. P., Du, L. F., & Li, F. (2026). Assessing local invasion in cervical cancer: the diagnostic performance of transrectal contrast-enhanced ultrasonography. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf283
Vancouver
Zhang J, Jin LF, Jia C, Zhang HP, Du LF, Li F. Assessing local invasion in cervical cancer: the diagnostic performance of transrectal contrast-enhanced ultrasonography. British Journal of Radiology. 2026. doi:10.1093/bjr/tqaf283
BibTeX
@article{Zhang2026,
author = {Zhang, Juan and Jin, Li-Fang and Jia, Chao and Zhang, Hui-Ping and Du, Lian-Fang and Li, Fan},
title = {Assessing local invasion in cervical cancer: the diagnostic performance of transrectal contrast-enhanced ultrasonography},
journal = {British Journal of Radiology},
year = {2026},
doi = {10.1093/bjr/tqaf283}
}
EUVIMED